Variations in intralipid tolerance in newborn infants.
Intravenous Intralipid tolerance tests (IVLTT) were done in 26 newborn infants of 26-40 wk gestational ages. The clearance constants (k2) ranged from 1.2-12.7 (%/min) after bolus injections given within 4.5 h (n = 12) or daily (n = 13). Significant variation (17-31%) occurred, similar to adults, and was unrelated to the time or dose given. Eleven infants received continuous Intralipid infusions for 10-24 h at a rate calculated to maintain a plasma Intralipid plateau concentration of 100 mg/dl. Nine infants did not exceed this optimal plasma level, although four could have tolerated more Intralipid. Two infants exceeded the ideal plasma concentration (greater than 100 mg/dl). All infants achieved and maintained plateaus within 5 h. Neither day-to-day variations nor the bolus dose used to establish clearance characteristics, accounted for the discrepancies in plateaus achieved. These studies identify some limitations of the IVLTT as a predictor of Intralipid utilization during continuous infusion, and the need for early monitoring of plasma Intralipid concentrations to optimize the therapeutic dose given to newborn infants.
D005217:Fat Emulsions, Intravenous / Q000378:metabolism*; D006801:Humans; D007206:Individuality; D007231:Infant, Newborn; D010289:Parenteral Nutrition, Total
D005217:Fat Emulsions, Intravenous